Dataset Information


Improvement in the definition of anti-HLA antibody profile in highly sensitized patients.

ABSTRACT: The definition of anti-HLA antibody profile in highly sensitized patients on a waiting list is crucial when virtual crossmatch is used in organ allocation systems, but also when used to identify the true deleterious anti-HLA antibodies. Here we propose different levels of risk based on the results of anti-HLA antibody testing in neat serum (N) and after sera dilution (DIL) and C1q test in 18 highly sensitized patients. This group was heterogeneous in terms of anti-HLA antibody titers and their ability to fix complement. After dilution, 15 out of 18 patients (83.3%) showed a reduction of positive bead counts whereas 4 patients showed a prozone effect and complement fixation was demonstrated. The high dilution of sera and ascertaining the complement fixation allow the accurate definition of risk anti-HLA antibody profiles in highly sensitized patients, as demonstrated in 5 of the sensitized patients who were transplanted.


PROVIDER: S-EPMC5291387 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5457814 | BioStudies
2019-01-01 | S-EPMC6660344 | BioStudies
2017-01-01 | S-EPMC5600102 | BioStudies
2019-01-01 | S-EPMC6426665 | BioStudies
2014-01-01 | S-EPMC6741594 | BioStudies
2019-01-01 | S-EPMC6687874 | BioStudies
2017-01-01 | S-EPMC5239985 | BioStudies
2018-01-01 | S-EPMC6093810 | BioStudies
2017-01-01 | S-EPMC5610566 | BioStudies
2014-01-01 | S-EPMC3964192 | BioStudies